KR23343

· Jiangxi Kvvit Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for KR23343, covering 2026-02-13 to 2026-02-13. Get the full timeline:

Most recent: Clinical Trial Update: Study of Single and Multiple Ascending Doses of KR23343 in Healthy Adult Participants [Phase 1]